Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-09-24

Clinical Trial Update: School-Based Treatment With ACT to Reduce Transmission [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating school-based treatment with artemisinin-based combination therapy to reduce malaria transmission has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Artemisinin-based combination therapy (ACT)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 4 | Status: COMPLETED